The global Cell Based Assays Market was valued at USD 12.13 billion in 2016 and is projected to reach USD 24.45 billion by 2025, growing at a CAGR of 8.1% from 2017 to 2025.
Cell based assays are widely used in diagnostics and pathology and is very reliable in terms of outcomes and predictability of one's health issues. Due to increased funding in research and development sector by private and govt. sector both, the use of clinical and medical devices is rising in the market value and demand.
Sample Infographics:
Market Dynamics:
1. Market Drivers
1.1 Increasing cases of Chronic diseases
1.2 Growingfunds and raising in the sector
1.3 Rise in demand for cell based assays
1.4 Increasing research activities in drug discoveries
2. Market Restraints
2.1 High implementation Cost
Market Segmentation:
1. Global Cell Based Assays Market, by Application:
1.1 Drug Discovery
1.2 Basic Research
1.3 Adme Studies
1.4 Predictive Toxicology
1.5 Other Applications
2. Global Cell Based Assays Market, by End User:
2.1 Pharmaceutical & Biotechnology Companies
2.2 Academic & Government Institutions
2.3 Contract Research Organizations
2.4 Other End Users
3. Global Cell Based Assays Market, by Products and services:
3.1 Consumables
3.1.1 Reagents
3.1.2 Assay Kits
3.1.2.1 Reporter Gene Assays
3.1.2.2 Cell Growth Assays
3.1.2.3 Second Messenger Assays
3.1.2.4 Cell Death Assays
3.1.2.5 Other Assays
3.1.3 Microplates
3.1.4 Cell Lines
3.1.4.1 Immortalized Cell Lines
3.1.4.2 Primary Cell Lines
3.1.4.3 Stem Cell Lines
3.1.5 Probes and Labels
3.1.6 Other Consumables
3.2 Instruments
3.3 Services
3.4 Software
4. Global Cell Based Assays Market, by Region:
4.1 North America (U.S., Canada, Mexico)
4.2 Europe (Germany, UK, France, Rest of Europe)
4.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
4.4 Latin America (Brazil, Argentina, Rest of Latin America)
4.5 Middle East & Africa
Competitive Landscape:
The major players in the market are as follows:
1. Becton, Dickinson and Company
2. Danaher Corporation
3. Thermo Fisher Scientific Inc.
4. General Electric Company
5. Merck KGaA
6. Perkinelmer, Inc.
7. Charles River Laboratories, Inc.
8. Lonza Group Ltd.
9. Cell Signaling Technology, Inc.
10. Promega Corporation
11. Cisbio Bioassays
12. Cell Biolabs, Inc.
13. Discoverx Corporation
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.
RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the Cell Based Assays Marketwas performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.
To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.
1 INTRODUCTION OF GLOBAL CELL BASED ASSAYS MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources
4 GLOBAL CELL BASED ASSAYS MARKETOUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework
5 GLOBAL CELL BASED ASSAYS MARKET, BY APPLICATION
5.1 Overview
5.2 Drug Discovery
5.3 Basic Research
5.4 Adme Studies
5.5 Predictive Toxicology
5.6 Others
6 GLOBAL CELL BASED ASSAYS MARKET, BY END USER
6.1 Overview
6.2 Pharmaceutical & Biotechnology Companies
6.3 Academic & Government Institutions
6.4 Contract Research Organizations
6.5 Others
7 GLOBAL CELL BASED ASSAYS MARKET, BY PRODUCTS AND SERVICES
7.1 Overview
7.2 Consumables
7.2.1 Reagents
7.2.2 Assay Kits
7.2.2.1 Reporter Gene Assays
7.2.2.2 Cell Growth Assays
7.2.2.3 Second Messenger Assays
7.2.2.4 Cell Death Assays
7.2.2.5 Other Assays
7.2.3 Microplates
7.2.4 Cell Lines
7.2.4.1 Immortalized Cell Lines
7.2.4.2 Primary Cell Lines
7.2.4.3 Stem Cell Lines
7.2.5 Probes and Labels
7.2.6 Others
7.3 Instruments
7.4 Services
7.5 Software
8 GLOBAL CELL BASED ASSAYS MARKET, BY GEOGRAPHY
8.1 Overview
8.2 North AmericaRegional Market Estimates and Forecasts, 2012 - 2025
8.2.1 U.S.
8.2.2 Canada
8.2.3 Mexico
8.3 EuropeRegional Market Estimates and Forecasts, 2012 - 2025
8.3.1 Germany
8.3.2 U.K.
8.3.3 France
8.3.4 Rest of Europe
8.4 Asia PacificRegional Market Estimates and Forecasts, 2012 - 2025
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Rest of Asia Pacific
8.5 Latin AmericaRegional Market Estimates and Forecasts, 2012 - 2025
8.5.1 Brazil
8.5.2 Argentina
8.6 Rest of the WorldRegional Market Estimates and Forecasts, 2012 - 2025
9 GLOBAL CELL BASED ASSAYS MARKETCOMPETITIVE LANDSCAPE
9.1 Overview
9.2 Company Market Share
9.3 Vendor Landscape
9.4 Key Development Strategies
10 COMPANY PROFILES
10.1 Becton, Dickinson and Company
10.1.1 Overview
10.1.2 Financial Performance
10.1.3 Product Outlook
10.1.4 Key Developments
10.2 Danaher Corporation
10.2.1 Overview
10.2.2 Financial Performance
10.2.3 Product Outlook
10.2.4 Key Developments
10.3 Thermo Fisher Scientific Inc.
10.3.1 Overview
10.3.2 Financial Performance
10.3.3 Product Outlook
10.3.4 Key Developments
10.4 General Electric Company
10.4.1 Overview
10.4.2 Financial Performance
10.4.3 Product Outlook
10.4.4 Key Developments
10.5 Merck KGaA
10.5.1 Overview
10.5.2 Financial Performance
10.5.3 Product Outlook
10.5.4 Key Developments
10.6 Perkinelmer, Inc.
10.6.1 Overview
10.6.2 Financial Performance
10.6.3 Product Outlook
10.6.4 Key Developments
10.7 Charles River Laboratories, Inc.
10.7.1 Overview
10.7.2 Financial Performance
10.7.3 Product Outlook
10.7.4 Key Developments
10.8 Lonza Group Ltd.
10.8.1 Overview
10.8.2 Financial Performance
10.8.3 Product Outlook
10.8.4 Key Developments
10.9 Cell Signaling Technology, Inc.
10.9.1 Overview
10.9.2 Financial Performance
10.9.3 Product Outlook
10.9.4 Key Developments
10.10 Promega Corporation
10.10.1 Overview
10.10.2 Financial Performance
10.10.3 Product Outlook
10.10.4 Key Developments
10.11 Sydney Essential Oil Co. (SEOC)
10.11.1 Overview
10.11.2 Financial Performance
10.11.3 Product Outlook
10.11.4 Key Developments
10.12 The Lebermuth Company
10.12.1 Overview
10.12.2 Financial Performance
10.12.3 Product Outlook
10.12.4 Key Developments
10.13 Cisbio Bioassays
10.13.1 Overview
10.13.2 Financial Performance
10.13.3 Product Outlook
10.13.4 Key Developments
10.14 Cell Biolabs, Inc.
10.14.1 Overview
10.14.2 Financial Performance
10.14.3 Product Outlook
10.14.4 Key Developments
10.15 Discoverx Corporation
10.15.1 Overview
10.15.2 Financial Performance
10.15.3 Product Outlook
10.15.4 Key Developments
11 Appendix
11.1 Related Reports
The Cloud-Based Cold Chain Management Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, m...
The Public Cloud Based Contact Center Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, m...
The IP-Based Mobile Games Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufacturers...
The Cloud-Based Project Management System Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscap...
The CRISPR Cell Line Development Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufa...
The Gene Knockdown Stable Cell Line Service Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landsc...
The Cell Line Customization Service Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, man...
The Cell Line Adaptation Service Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufa...
Market Overview
The Asia Pacific Banking as a Service (BaaS) Market is set to experience substantial growth from 2024 to 2034, driven by the region's rapid digitalization, the increasing adoption of cloud-based technologies, and the growing demand for seamless financial services. As fin...
Market Overview
The Europe Banking as a Service (BaaS) Market is set to experience significant growth from 2024 to 2034, driven by the rapid digital transformation of the financial sector, the increasing adoption of embedded finance solutions, and the rising demand for seamless customer...